Aptevo Therapeutics (NASDAQ:APVO) announced two additional frontline Acute Myeloid Leukemia (AML) patients have achieved ...
Pacylex Pharmaceuticals Inc. (Pacylex) is a clinical-stage pharmaceutical company and world leader in developing ...
Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...
Announced Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) with ...
The journey of fighting Acute Myeloid Leukemia (AML) in India encompasses severe physical and emotional challenges for both ...
The rate of cGVHD-free survival was 78% at 1 year in patients who received Orca-T compared with 38% among patients who ...
Dose expansion in Phase 1 CARDINAL trial of TERN-701 for chronic myeloid leukemia (CML) expected to initiate in 2Q25 with additional safety and ...
GLP-1 RA use was associated with significantly lower risk of certain cancers compared with metformin use and insulin use.
The Asian Parent on MSN3d
Beware! Recognize 9 Signs of Leukemia in Children and How to Treat ItTanda leukemia kadang samar dan mungkin mirip dengan gejala penyakit lain. Apa saja gejala leukemia pada anak? Berikut ciri-cirinya.
Identifying the JAK2V617F mutation has improved understanding of what causes overproduction of red blood cells, platelets, ...
Actinium Pharma inks research pact with Memorial Sloan Kettering to support further clinical expansion of Actimab-A's backbone therapy strategy: New York Saturday, March 22, 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback